Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Freeman

Showing results (211-220 of 244) with videos related to

Pageof 25
Sort By:
European Urology|May 28, 2025
Magnetic Resonance Imaging-led Risk-adapted Active Surveillance for Prostate Cancer: Updated Results from a Large Cohort StudyCameron Englman, Busola Adebusoye, Davide Maffei, et al.
BJU International|March 1, 2023
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imagingJuan Morote, Hayley Pye, Miriam Campistol, et al.
The Journal of Urology|November 23, 2016
The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED-A Randomized, Placebo Controlled, Double-Blind Clinical TrialCaroline M Moore, Nicola L Robertson, Fatima Jichi, et al.
European Journal of Radiology|April 1, 2023
A semi-automated software program to assess the impact of second reads in prostate MRI for equivocal lesions: results from a UK tertiary referral centreAlexandre Woernle, Louise Dickinson, Steven Lelie, et al.
European Urology|December 12, 2018
The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk StratificationSami Hamid, Ian A Donaldson, Yipeng Hu, et al.
The Lancet. Oncology|March 27, 2025
Effect of NeuroSAFE-guided RARP versus standard RARP on erectile function and urinary continence in patients with localised prostate cancer (NeuroSAFE PROOF): a multicentre, patient-blinded, randomised, controlled phase 3 trialEoin Dinneen, Ricardo Almeida-Magana, Tarek Al-Hammouri, et al.
European Urology Oncology|August 15, 2019
A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at RiskSaiful Miah, Feargus Hosking-Jervis, Martin J Connor, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical ProstatectomyEoin Dinneen, Clare Allen, Tom Strange, et al.
The Prostate|February 27, 2019
PEOPLE: PatiEnt prOstate samPLes for rEsearch, a tissue collection pathway utilizing magnetic resonance imaging data to target tumor and benign tissue in fresh radical prostatectomy specimensSusan Heavey, Helena Costa, Hayley Pye, et al.
BMC Medical Imaging|November 16, 2019
Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancerSola Adeleke, Arash Latifoltojar, Harbir Sidhu, et al.
Pageof 25

Showing results (211-220 of 244) with videos related to

Sort By:
Pageof 25
European Urology|May 28, 2025
Magnetic Resonance Imaging-led Risk-adapted Active Surveillance for Prostate Cancer: Updated Results from a Large Cohort StudyCameron Englman, Busola Adebusoye, Davide Maffei, et al.
BJU International|March 1, 2023
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imagingJuan Morote, Hayley Pye, Miriam Campistol, et al.
The Journal of Urology|November 23, 2016
The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED-A Randomized, Placebo Controlled, Double-Blind Clinical TrialCaroline M Moore, Nicola L Robertson, Fatima Jichi, et al.
European Journal of Radiology|April 1, 2023
A semi-automated software program to assess the impact of second reads in prostate MRI for equivocal lesions: results from a UK tertiary referral centreAlexandre Woernle, Louise Dickinson, Steven Lelie, et al.
European Urology|December 12, 2018
The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk StratificationSami Hamid, Ian A Donaldson, Yipeng Hu, et al.
The Lancet. Oncology|March 27, 2025
Effect of NeuroSAFE-guided RARP versus standard RARP on erectile function and urinary continence in patients with localised prostate cancer (NeuroSAFE PROOF): a multicentre, patient-blinded, randomised, controlled phase 3 trialEoin Dinneen, Ricardo Almeida-Magana, Tarek Al-Hammouri, et al.
European Urology Oncology|August 15, 2019
A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at RiskSaiful Miah, Feargus Hosking-Jervis, Martin J Connor, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical ProstatectomyEoin Dinneen, Clare Allen, Tom Strange, et al.
The Prostate|February 27, 2019
PEOPLE: PatiEnt prOstate samPLes for rEsearch, a tissue collection pathway utilizing magnetic resonance imaging data to target tumor and benign tissue in fresh radical prostatectomy specimensSusan Heavey, Helena Costa, Hayley Pye, et al.
BMC Medical Imaging|November 16, 2019
Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancerSola Adeleke, Arash Latifoltojar, Harbir Sidhu, et al.
Pageof 25